company background image
HYPM.Y logo

Hypera OTCPK:HYPM.Y Stock Report

Last Price

US$3.73

Market Cap

US$2.5b

7D

-1.2%

1Y

-46.0%

Updated

07 Nov, 2024

Data

Company Financials +

Hypera S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hypera
Historical stock prices
Current Share PriceR$3.73
52 Week HighR$7.90
52 Week LowR$3.71
Beta0.40
11 Month Change-25.74%
3 Month Change-30.22%
1 Year Change-46.00%
33 Year Change-29.99%
5 Year Change-54.51%
Change since IPO-74.30%

Recent News & Updates

Recent updates

Shareholder Returns

HYPM.YUS PharmaceuticalsUS Market
7D-1.2%-4.5%2.3%
1Y-46.0%10.9%35.1%

Return vs Industry: HYPM.Y underperformed the US Pharmaceuticals industry which returned 10.9% over the past year.

Return vs Market: HYPM.Y underperformed the US Market which returned 35.1% over the past year.

Price Volatility

Is HYPM.Y's price volatile compared to industry and market?
HYPM.Y volatility
HYPM.Y Average Weekly Movement7.1%
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.2%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.9%

Stable Share Price: HYPM.Y has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: HYPM.Y's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199910,301Breno Pires de Oliveirawww.hypera.com.br

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, Equilibrisse, balance, Flavonid, Histamin, neofresh, neolefrin, neoquimica Vitamins, Neosorum, and Torsilax brands; and over-the-counter drugs under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand.

Hypera S.A. Fundamentals Summary

How do Hypera's earnings and revenue compare to its market cap?
HYPM.Y fundamental statistics
Market capUS$2.45b
Earnings (TTM)US$297.45m
Revenue (TTM)US$1.41b

8.0x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HYPM.Y income statement (TTM)
RevenueR$8.00b
Cost of RevenueR$3.05b
Gross ProfitR$4.95b
Other ExpensesR$3.26b
EarningsR$1.69b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 13, 2024

Earnings per share (EPS)2.68
Gross Margin61.86%
Net Profit Margin21.17%
Debt/Equity Ratio84.8%

How did HYPM.Y perform over the long term?

See historical performance and comparison

Dividends

5.7%

Current Dividend Yield

30%

Payout Ratio